Tag
In a new study, about 30 percent of people with long-haul COVID seemed to meet the diagnostic criteria for fibromyalgia.
By Kelsey Kloss
There are actionable steps you can take to keep yourself and your loved one safe, especially if you may be at increased risk for severe COVID-19.
By Kelsey Kloss
Trying to navigate the latest guidance for additional COVID-19 vaccine doses and COVID-19 booster shots when you are immunocompromised isn’t easy. Here is what we know so far.
By Kelsey Kloss
Tocilizumab (Actemra), which is used to treat rheumatoid and other inflammatory arthritis, is in short supply due to its emergency use authorization (EUA) as a COVID-19 treatment. Here’s what to know about the issue and what to do if you have trouble getting treatment.
In the Global Healthy Living Foundation’s latest COVID-19 Patient Support Program poll, more than half of respondents said they have already received their third COVID-19 vaccine dose within weeks of it being approved.
By Helen Massy
A new study found that disease flares may be uncommon after receiving the COVID-19 vaccine, particularly for patients who haven’t experienced a flare in six months.
Many members of the CreakyJoints and Global Healthy Living Foundation community immediately sought to receive a third vaccine dose after they became available in the U.S. to people who are immunocompromised. Here’s a round-up of what it’s been like so far.
In the Global Healthy Living Foundation’s latest COVID-19 Patient Support Program poll, 72 percent of immunocompromised patients said they are moderately to very worried about the Delta variant of COVID-19 — and it’s affecting their everyday behaviors and habits.
By Kelsey Kloss
The treatment doesn’t replace a vaccine, but it’s a helpful tool in protecting yourself against infection if you’re high-risk for severe COVID-19 outcomes.
Researchers looked at the characteristics and outcomes of COVID-19 breakthrough infections among fully vaccinated people with rheumatic disease, such as rheumatoid arthritis and lupus. They found that, though cases were limited, the outcomes were more severe among this group than in the general population.
By 
By 
